Gabrielle Agin-Liebes, PhD
Professional Services CNTRCT
Neurology
School of Medicine
Gabby is a licensed clinical psychologist. She is currently a National Institute on Drug Abuse T32 Research Fellow in Substance Use Disorders Treatment and Services Research at UCSF within the Psychedelics Divisions of Neuroscape.
Show full bio (130 words) Hide full bio
Her research explores transdiagnostic psychological mechanisms (e.g., emotion regulation, metacognition, self-transcendence) underlying the therapeutic outcomes in treatments of mood, anxiety and substance use disorders. She also conducts qualitative research on psychotherapy-related change processes. She has over 11 years of experience working as a therapist and investigator on FDA-approved clinical trials with psilocybin at New York University, Yale and UC San Francisco (UCSF). Her research applies quantitative and qualitative methodologies to study the role of emotion regulation and metacognitive processes (e.g., mindfulness/self-compassion and reappraisal) targeted by psychedelic-assisted therapies for the treatment of addiction, existential distress, and PTSD. Her 2020 study, which found that psilocybin-assisted therapy was associated with improvements 4.5 years after treatment, garnered media attention in several global news outlets including Time, Newsweek, and CNN.
Interests
Show all (5) Hide
- addiction
- opioid use disorder
- psilocybin-assisted interventions
- chronic pain
- mindfulness-based interventions
Websites
Show all (1) Hide
- My Personal Site (GabbyPhD.com)
Publications (19)
Top publication keywords:
YogaAlcoholismDepressive Disorder, MajorMindfulnessBanisteriopsisPsychotherapyPsilocybinDepressive Disorder, Treatment-ResistantHallucinogensDrug ToleranceAgaricalesOpioid-Related DisordersHydromorphoneMeditationExistentialism
-
Naturalistic Use of Mescaline Is Associated with Self-Reported Psychiatric Improvements and Enduring Positive Life Changes.
ACS pharmacology & translational science 2021 Agin-Liebes G, Haas TF, Lancelotta R, Uthaug MV, Ramaekers JG, Davis AK -
Individual Experiences in Four Cancer Patients Following Psilocybin-Assisted Psychotherapy.
Frontiers in pharmacology 2018 Malone TC, Mennenga SE, Guss J, Podrebarac SK, Owens LT, Bossis AP, Belser AB, Agin-Liebes G, Bogenschutz MP, Ross S -
Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial.
Journal of psychopharmacology (Oxford, England) 2016 Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, Schmidt BL -
Therapeutic Effects of Ceremonial Ayahuasca Use for Methamphetamine Use Disorders and Other Mental Health Challenges: Case Studies in an Indigenous Community in Sonora, Mexico.
Journal of psychoactive drugs 2023 Loizaga-Velder A, Giovannetti C, Campoy Gomez R, Castillo Valenzuela TE, Ochoa Jaime GR, Agin-Liebes G, Marcus O, Rush B -
Reports of self-compassion and affect regulation in psilocybin-assisted therapy for alcohol use disorder: An interpretive phenomenological analysis.
Psychology of addictive behaviors : journal of the Society of Psychologists in Addictive Behaviors 2023 Agin-Liebes G, Nielson EM, Zingman M, Kim K, Haas A, Owens LT, Rogers U, Bogenschutz M
Show all (14 more) Hide
-
Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.
Frontiers in epidemiology 2022 Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT -
Prospective examination of the therapeutic role of psychological flexibility and cognitive reappraisal in the ceremonial use of ayahuasca.
Journal of psychopharmacology (Oxford, England) 2022 Agin-Liebes G, Zeifman R, Luoma JB, Garland EL, Campbell WK, Weiss B -
Comment and Response: (Lugo-Radillo & Cortez-Lopez, 2020) Long-Term Amelioration of OCD Symptoms in a Patient with Chronic Consumption of Psilocybin-Containing Mushrooms.
Journal of psychoactive drugs 2022 Fitzpatrick CM, Anderson BT, Agin-Liebes G, Guydish J -
Assessing the Acceptability of Yoga Among Patients with and without Chronic Pain Enrolled in a Licensed Opioid Treatment Program.
International journal of yoga therapy 2022 Ahmadi E, Evans C, Agin-Liebes G, Tompkins DA -
Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.
Current topics in behavioral neurosciences 2022 Agin-Liebes G, Davis AK -
Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.
Journal of psychoactive drugs 2021 Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J -
Methadone maintenance patients lack analgesic response to a cumulative intravenous dose of 32 mg of hydromorphone.
Drug and alcohol dependence 2021 Agin-Liebes G, Huhn AS, Strain EC, Bigelow GE, Smith MT, Edwards RR, Gruber VA, Tompkins DA -
Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis
Journal of Humanistic Psychology 2021 Agin-Liebes, G., Ekman, E., Anderson, B., Malloy, M., Haas, A., & Woolley, J. -
Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.
ACS pharmacology & translational science 2021 Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE -
Patient experiences of psilocybin-assisted psychotherapy: an interpretative phenomenological analysis
J Humanist Psychol 2020 Belser AB, Agin-Liebes G, Swift TC, Terrana S, Devenot N, Friedman HL, Guss J, Bossis A, Ross S. -
Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study.
EClinicalMedicine 2020 Anderson BT, Danforth A, Daroff PR, Stauffer C, Ekman E, Agin-Liebes G, Trope A, Boden MT, Dilley PJ, Mitchell J, Woolley J -
Long-term follow-up of psilocybin-assisted psychotherapy for psychiatric and existential distress in patients with life-threatening cancer.
Journal of psychopharmacology (Oxford, England) 2020 Agin-Liebes GI, Malone T, Yalch MM, Mennenga SE, Ponté KL, Guss J, Bossis AP, Grigsby J, Fischer S, Ross S -
Cancer at the dinner table: experiences of psilocybin-assisted psychotherapy for the treatment of cancer-related distress
J Humanist Psychol 2017 Swift TC*, Belser AB*, Agin-Liebes G*, Devenot N, Terrana S, Friedman HL, Guss J, Bossis AP, Ross S. [*denotes co-first authorship] -
The child and adolescent mental health studies program (CAMS) at New York University
Neuropsychiatrie de l'enfance et de l'adolescence 2012 Shatkin J, Agin-Liebes G.